{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"EPA\", docket_id = \"EPA-HQ-OAR-2006-0159\" and posted_year = 2006 sorted by posted_date descending", "rows": [["EPA-HQ-OAR-2006-0159-0033", "EPA", "EPA-HQ-OAR-2006-0159", "Notes from meeting between representatives from Amphastar Pharmaceuticals, Inc./Armstrong Pharmaceuticals Inc. and USEPA on November 30, 2006", "Supporting & Related Material", "Meeting/Teleconference Materials", "2006-12-06T05:00:00Z", 2006, 12, null, null, "2012-03-24T19:34:44Z", null, 0, 0, "09000064801e76bb"], ["EPA-HQ-OAR-2006-0159-0001", "EPA", "EPA-HQ-OAR-2006-0159", "Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2007", "Proposed Rule", "Federal Register Document", "2006-11-03T12:49:10Z", 2006, 11, "2006-11-03T12:49:10Z", "2006-12-05T04:59:59Z", "2011-06-11T16:02:04Z", "E6-18581", 0, 0, "09000064801dd141"], ["EPA-HQ-OAR-2006-0159-0021", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for the Regulatory Impact Analysis RIA", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:45Z", null, 0, 0, "09000064801dbe94"], ["EPA-HQ-OAR-2006-0159-0008", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for Schering Plough's response to Section 114 letter", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:37Z", null, 0, 0, "09000064801db554"], ["EPA-HQ-OAR-2006-0159-0018", "EPA", "EPA-HQ-OAR-2006-0159", "SAMPLE 114 Letter for Allocation of Essential Use Allowances for Calendar Year 2007", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:43Z", null, 0, 0, "09000064801dbe5e"], ["EPA-HQ-OAR-2006-0159-0017", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for Armstrong Pharmaceuticals, Inc.\u2019s response to 114 letter regarding CFC stocks owned", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:42Z", null, 0, 0, "09000064801dbe40"], ["EPA-HQ-OAR-2006-0159-0007", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for Wyeth's response to Section 114 letter", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:37Z", null, 0, 0, "09000064801db534"], ["EPA-HQ-OAR-2006-0159-0016", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for Boehringer Ingelheim Pharmaceuticals, Inc.\u2019s response to 114 letter regarding CFC stocks owned", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:42Z", null, 0, 0, "09000064801dbe3a"], ["EPA-HQ-OAR-2006-0159-0013", "EPA", "EPA-HQ-OAR-2006-0159", "Schering-Plough's response to 114 letter regarding CFC stocks owned", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:40Z", null, 0, 0, "09000064801dbd2b"], ["EPA-HQ-OAR-2006-0159-0015", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for Wyeth's response to section 114 letter regarding CFC stocks owned", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:41Z", null, 0, 0, "09000064801dbe1d"], ["EPA-HQ-OAR-2006-0159-0023", "EPA", "EPA-HQ-OAR-2006-0159", "Decision IV/25- Essential uses", "Supporting & Related Material", "Guidance, Interpretation, Policy, Procedure", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:46Z", null, 0, 0, "09000064801dbef4"], ["EPA-HQ-OAR-2006-0159-0004", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for Boehringer Ingelheim Pharmaceuticals, Inc\u2019s response to Section 114 letter", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:35Z", null, 0, 0, "09000064801d7f4b"], ["EPA-HQ-OAR-2006-0159-0006", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for 3M\u2019s response to Section 114 letter", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:36Z", null, 0, 0, "09000064801d7fbd"], ["EPA-HQ-OAR-2006-0159-0022", "EPA", "EPA-HQ-OAR-2006-0159", "Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2006", "Supporting & Related Material", "Federal Register Document", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2011-06-11T16:02:04Z", null, 0, 0, "09000064801dbedc"], ["EPA-HQ-OAR-2006-0159-0024", "EPA", "EPA-HQ-OAR-2006-0159", "Decision XVI/12-Essential-use nominations for Parties not operating under paragraph 1 of Article 5 of the Montreal Protocol for controlled substances for 2005 and 2006", "Supporting & Related Material", null, "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:47Z", null, 0, 0, "09000064801dbf01"], ["EPA-HQ-OAR-2006-0159-0020", "EPA", "EPA-HQ-OAR-2006-0159", "Decision XVII/5: Essential-use nominations for Parties not operating under paragraph 1 of Article 5 for controlled substances for 2006 and 2007", "Supporting & Related Material", "Guidance, Interpretation, Policy, Procedure", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:44Z", null, 0, 0, "09000064801dbe7e"], ["EPA-HQ-OAR-2006-0159-0010", "EPA", "EPA-HQ-OAR-2006-0159", "SAMPLE 114 LETTER for CFC Stocks Owned", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:38Z", null, 0, 0, "09000064801dbcf0"], ["EPA-HQ-OAR-2006-0159-0019", "EPA", "EPA-HQ-OAR-2006-0159", "Letter to Brian McLean, Director, Office of Atmospheric Programs, USEPA re: responding to the March 23 letter requesting the Food and Drug Administration's (FDA) re: 2007 Essential Use Allowances", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:44Z", null, 0, 0, "09000064801dbe6a"], ["EPA-HQ-OAR-2006-0159-0003", "EPA", "EPA-HQ-OAR-2006-0159", "Letter to Mr. Andrew C. von Eschenbach, M.D., Acting Commissioner of Food and Drugs, Food and Drug Administration", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:34Z", null, 0, 0, "09000064801d7e7f"], ["EPA-HQ-OAR-2006-0159-0005", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for Inyx USA, Ltd.\u2019s response to Section 114 letter", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:36Z", null, 0, 0, "09000064801d7f7a"], ["EPA-HQ-OAR-2006-0159-0011", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for Inyx USA Ltd.'s response to 114 letter regarding CFC stocks owned", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:39Z", null, 0, 0, "09000064801dbd07"], ["EPA-HQ-OAR-2006-0159-0002", "EPA", "EPA-HQ-OAR-2006-0159", "CBI Placeholder for Armstrong Pharmaceuticals, Inc.\u2019s response to Section 114 letter", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:34Z", null, 0, 0, "09000064801d76c1"], ["EPA-HQ-OAR-2006-0159-0014", "EPA", "EPA-HQ-OAR-2006-0159", "Honeywell's response to 114 letter regarding CFC stocks owned", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:41Z", null, 0, 0, "09000064801dbd47"], ["EPA-HQ-OAR-2006-0159-0012", "EPA", "EPA-HQ-OAR-2006-0159", "3M's response to 114 letter regarding CFC stocks owned", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:40Z", null, 0, 0, "09000064801dbd1e"], ["EPA-HQ-OAR-2006-0159-0009", "EPA", "EPA-HQ-OAR-2006-0159", "United States' Nomination of The Aerosol Metered Dose Inhaler (MDI) As An Essential Use", "Supporting & Related Material", null, "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:38Z", null, 0, 0, "09000064801dbc8d"]], "truncated": false, "filtered_table_rows_count": 25, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "EPA", "p1": "EPA-HQ-OAR-2006-0159", "p2": "2006"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=EPA&docket_id=EPA-HQ-OAR-2006-0159&posted_year=2006", "results": [{"value": "EPA", "label": "EPA", "count": 25, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=EPA-HQ-OAR-2006-0159&posted_year=2006", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=EPA&docket_id=EPA-HQ-OAR-2006-0159&posted_year=2006", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 24, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=EPA&docket_id=EPA-HQ-OAR-2006-0159&posted_year=2006&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 1, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=EPA&docket_id=EPA-HQ-OAR-2006-0159&posted_year=2006&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=EPA&docket_id=EPA-HQ-OAR-2006-0159&posted_year=2006", "results": [{"value": 2006, "label": 2006, "count": 25, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=EPA&docket_id=EPA-HQ-OAR-2006-0159", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=EPA&docket_id=EPA-HQ-OAR-2006-0159&posted_year=2006&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=EPA&docket_id=EPA-HQ-OAR-2006-0159&posted_year=2006&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=EPA&docket_id=EPA-HQ-OAR-2006-0159&posted_year=2006&_facet=posted_month"}, {"name": "last_modified", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=EPA&docket_id=EPA-HQ-OAR-2006-0159&posted_year=2006&_facet=last_modified"}, {"name": "posted_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=EPA&docket_id=EPA-HQ-OAR-2006-0159&posted_year=2006&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=EPA&docket_id=EPA-HQ-OAR-2006-0159&posted_year=2006&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=EPA&docket_id=EPA-HQ-OAR-2006-0159&posted_year=2006&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=EPA&docket_id=EPA-HQ-OAR-2006-0159&posted_year=2006&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1398.6425650073215, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}